Nurse Practitioner · Duarte, CA
NPI
1871904151
Since 2014
Specialty
Nurse Practitioner
Code 163WC0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 Duarte Rd
Duarte, CA, 91010
Phone (626) 256-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
618 services
Medicare patients, 2024
338
Average age 75
Drug cost, 2024
$5.4M
1,385 prescriptions
Company payments, 2025
$76.41
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin Gerendash was code 99213 (office e&m - established), 371 times for 239 patients. In total Benjamin Gerendash billed 618 services in 8 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 371 | 239 | $46.31 | $17K |
| 99214 Office E&M - Established | Facility | 137 | 107 | $69.51 | $9,522 |
| 99213 Office E&M - Established | Office | 31 | 24 | $62.84 | $1,948 |
| 99212 Office E&M - Established | Office | 28 | 17 | $35.89 | $1,005 |
| 99215 Office E&M - Established | Facility | 15 | 15 | $98.46 | $1,477 |
By year: 2022 $46K for 775 services; 2023 $20K for 400 services; 2024 $34K for 618 services.
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin Gerendash prescribed most often to Medicare patients was Prednisone, with 198 prescriptions and refills. In total Benjamin Gerendash wrote 1,385 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 198 | 259 | 43 | $993 |
| Abiraterone Acetate Generic | 157 | 157 | 28 | $356K |
| Cabometyx Cabozantinib S-Malate | 85 | 85 | 12 | $2.1M |
| Orgovyx Relugolix | 82 | 84 | 14 | $225K |
| Tamsulosin Hcl Generic | 63 | 131 | 15 | $854 |
| Nubeqa Darolutamide | 49 | 49 | Under 11 | $621K |
| Xtandi Enzalutamide | 48 | 48 | 11 | $656K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 36 | 36 | 15 | $767 |
| Triamcinolone Acetonide Generic | 33 | 33 | 18 | $298 |
| Eliquis Apixaban | 31 | 53 | Under 11 | $30K |
| Erleada Apalutamide | 30 | 33 | Under 11 | $400K |
| Lenvima Lenvatinib Mesylate | 27 | 27 | Under 11 | $627K |
| Ondansetron Odt Ondansetron | 26 | 26 | 19 | $407 |
| Pantoprazole Sodium Generic | 23 | 39 | Under 11 | $312 |
| Lisinopril Generic | 21 | 43 | Under 11 | $147 |
Brand drugs: - claims; generic drugs: 939 claims; opioid claims: 67.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin Gerendash $76.41 ($76.41 in general payments such as food, travel and fees) from 1 company. The largest payer was Exelixis Inc. with $76.41.
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. EXEL | 3 | $76.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.